The Target Validation Pathfinder Grant scheme provides funds for small, translational research projects that show potential for an application to the Dementia Consortium or collaboration with the ARUK Drug Discovery Alliance.
The lead applicant and point of contact must be based in an academic/research institution, either in the UK or abroad. Co-applicants from small and medium enterprises are permitted. The Lead applicant is expected to have a contract (fixed term or tenure) which covers the proposed duration of the grant. If the Lead applicant does not hold a tenure appointment, the application must include a co-applicant that does.
Funding: Up to £50,000. This can cover staff salaries, equipment, animals, running costs, or any combinations of these.
Deadline: 15th April 2020.